|Rapid Review Complete
|Aclidinium bromide/formoterol fumarate dihydrate
|For treatment to relieve symptoms in adult patients with COPD. (Maintenance bronchodilator)
|Rapid review outcome
|Full Pharmacoeconomic Evaluation Recommended at submitted price.
The company has not submitted a HTA dossier to the NCPE therefore the cost effectiveness of the technology could not be proven.